文献速递白血病

基于RNA测序的微小RNA特征作为儿童B细胞急性淋巴细胞白血病复发的独立预测因素

RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
PubMed 文献 · Blood Adv · 2024-01-01

该研究对180例儿童B细胞前体急性淋巴细胞白血病(BCP-ALL)患者(含43对诊断与复发配对样本)进行miRNA和mRNA测序分析,发现以miRNA下调为特征的miR-low聚类(MLC)与已知遗传亚型无关,且MLC患者无事件生存期显著缩短(中位21个月 vs 33个月;log-rank P=3×10^-5),该预后价值在高超二倍体ALL中仍保留并在验证队列中确认。

要点

  • MLC特征以miRNA下调为主,与已知遗传亚型无关。
  • MLC患者无事件生存期显著缩短(中位21 vs 33个月;log-rank P=3×10^-5)。
  • 诊断时非MLC特征在复发时常转为MLC(23例中9例;Fisher精确检验P=.039)。

核心结论

  • 基于miRNA-mRNA整合分析的无偏分子分层可识别儿童BCP-ALL中具有新型预后miRNA特征的高危亚组,可能改善临床结局。

研究设计与样本

  • 研究纳入180例儿童BCP-ALL患者,包括43对诊断与复发配对样本,进行miRNA测序和mRNA测序分析。

主要发现

  • MLC患者无事件生存期显著短于非MLC患者(中位21 vs 33个月;log-rank P=3×10^-5),该预后差异在高超二倍体ALL中仍保留。
  • 验证队列中确认了MLC特征的不良预后价值。
  • 同一患者诊断时非MLC特征(23例中9例;Fisher精确检验P=.039)在复发时常转为MLC特征。
  • MLC转录特征富集MYC靶基因和氧化磷酸化基因,内含子保留减少,DICER1低表达。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aberrant micro-RNA (miRNA) expression profiles have been associated with disease progression and clinical outcome in pediatric cancers. However, few studies have analyzed genome-wide dysregulation of miRNAs and messenger RNAs (mRNAs) in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). To identify novel prognostic factors, we comprehensively investigated miRNA and mRNA sequencing (miRNA-seq and mRNA-seq) data in pediatric BCP-ALL samples with poor outcome. We analyzed 180 patients, including 43 matched pairs at diagnosis and relapse. Consensus clustering of miRNA expression data revealed a distinct profile characterized by mainly downregulation of miRNAs (referred to as an miR-low cluster [MLC]). The MLC profile was not associated with any known genetic subgroups. Intriguingly, patients classified as MLC had significantly shorter event-free survival (median 21 vs 33 months; log-rank P = 3 ×10-5). Furthermore, this poor prognosis was retained even in hyperdiploid ALL. This poor prognostic MLC profiling was confirmed in the validation cohort. Notably, non-MLC profiling at diagnosis (n = 9 of 23; Fisher exact test, P = .039) often changed into MLC profiling at relapse for the same patient. Integrated analysis of miRNA-seq and mRNA-seq data revealed that the transcriptional profile of MLC was characterized by enrichment of MYC target and oxidative phosphorylation genes, reduced intron retention, and low expression of DICER1. Thus, our miRNA-mRNA integration approach yielded a truly unbiased molecular stratification of pediatric BCP-ALL cases based on a novel prognostic miRNA signature, which may lead to better clinical outcomes.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kubota H, Ueno H, Tasaka K, et al. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia. Blood Adv. 2024. PMID: 38127276. doi:10.1182/bloodadvances.2023011583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。